Inappropriate liver transplantation in a child with Alpers-Huttenlocher syndrome misdiagnosed as valproate-induced acute liver failure

Pediatric Transplantation

Volumn 4, Issue 1, 2000, Pages 67-71

  Delarue, A ^a   Paut, O ^a   Guys, J M ^a   Montfort, M F ^a   Lethel, V ^a   Roquelaure, B ^a   Pellissier, J F ^a   Sarles, J ^a   Camboulives, J ^a  

^a TIMONE HOSPITAL   (France)

Author keywords

Alpers Huttenlocher syndrome; Child; Liver failure; Liver transplantation; Mitochondria; Respiratory chain deficiency; Valproic acid

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; PHENOBARBITAL; VALPROIC ACID;

ALPERS DISEASE; ANTICONVULSANT THERAPY; ARTICLE; AUTOSOMAL RECESSIVE DISORDER; CASE REPORT; CHILD; DIAGNOSTIC ERROR; DIFFERENTIAL DIAGNOSIS; DRUG INDUCED DISEASE; ENZYME DEFICIENCY; HUMAN; LIVER FAILURE; LIVER TRANSPLANTATION; MALE; MITOCHONDRIAL RESPIRATION; MITOCHONDRION; SEIZURE;

ANTICONVULSANTS; BRAIN; CHILD, PRESCHOOL; DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC ERRORS; DIFFUSE CEREBRAL SCLEROSIS OF SCHILDER; HUMANS; LIVER FAILURE, ACUTE; LIVER TRANSPLANTATION; MAGNETIC RESONANCE IMAGING; MALE; MEDICAL ERRORS; MITOCHONDRIAL MYOPATHIES; VALPROIC ACID;

EID: 0033973118     PISSN: 13973142     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-3046.2000.00090.x     Document Type: Article

References (23)

1. 4-VPA, a toxic metabolite of valproic acid. Science 1987: 235: 890-893.
2. COULTER DL. Carnitine and valproate toxicity. J Child Neurol 1991: 6: 7-14.
3. PAPAZIAN O, CANIZALES E, ALFONSO I, ARCHILA R, DUCHOWNY M, AICARDI J. Reversible dementia and apparent brain atrophy during valproate therapy. Ann Neurol 1995: 38: 687-691.
4. WILLMORE LJ, TRIGGS WJ, PELLOCK JM. Valproate toxicity: risk-screening strategies. J Child Neurol 1991: 6: 3-6.
5. LENN NJ, ELLIS WG, WASHBURN ER, RUEBNER B. Fatal hepatocerebral syndrome in siblings discordant for exposure to valproate. Epilepsia 1990: 31: 578-583.
6. BICKNESE AR, MAY W, HICKEY WF, DODSON WE. Early childhood hepatocerebral degeneration misdiagnosed as valproate hepatotoxicity. Ann Neurol 1992: 32: 767-775.
7. SCHEFFNER D, KÖNIG S, RAUTERBERG-RULAND I, KOCHEN W, HOFMAN WJ, UNKELBACH S. Fatal liver failure with valproate therapy. Epilepsia 1988: 29: 530-542.
8. NARKEWICZ MR, SOKOL RJ, BECKWITH B, SONDHEIMER J, SILVERMAN A. Liver involvement in Alpers' disease. J Pediatr 1991: 119: 260-267.
9. DREIFUSS FE, LANGER DH, MOLINE KA, MAXWELL JE. Valproic: acid hepatic fatalities. II. US experience since 1984. Neurology 1989: 39: 201-207.
10. HUTTENLOCHER PR, SOLITARE GB, ADAMS G. Infantile diffuse cerebral degeneration with hepatic cirrhosis. Arch Neurol 1976: 33: 186-192.
11. WÖRLE H, KÖHLER B, SCHLOTE W, WINKLER P, BASTANIER CK. Progressive degeneration of childhood with liver disease (Alpers-Huttenlocher disease) with cytochrome oxidase deficiency presenting with epilepsia partialis continua as the first clinical manifestation. Clin Neuropathol 1998: 17: 63-68.
12. HARDING B. Progressive neuronal degeneration of childhood with liver disease (Alpers Huttenlocher Syndrome) presenting in young adult. J Neurol Neurosurg Psychiatry 1995: 58: 320-325.
13. PAULUS W, PEIFFER J. Intracerebral distribution of mitochondrial abnormalities in 21 cases of infantile spongy dystrophy. J Neurol Sci 1990: 95: 49-62.
14. PRICK MJJ, GABREËLS FJM, RENIER WO, TRIJBELS FM, SENGERS RCA, SLOOFF JL. Progressive infantile polio-dystrophy. Association with disturbed pyruvate oxidation in muscle and liver. Arch Neurol 1981: 38: 767-772.
15. MUNNICH A, ROTIG A, CHRETIEN D, SAUDUBRAY JM, CORMIER V, RUSTIN P. Clinical presentation and laboratory investigations in respiratory chain deficiencies. Eur J Pediatr 1996: 155: 262-274.
16. CHABROL B, MANCINI J, CHRETIEN D, RUSTIN P, MUNNICH A, PINSARD N. Valproate-induced hepatic failure in a case of cytochrome-c oxidase deficiency. Eur J Pediatr 1994: 153: 133-135.
17. BOYD SG. Progressive neuroneal degeneration of childhood with liver disease (Alpers' disease): Characteristic neurophysiological features. Neuropediatrics 1986: 17: 76-80.
18. CORMIER-DAIRE V, CHRETIEN D, RUSTIN P, et al. Neonatal and delayed-onset liver involvement in disorders of oxidative phosphorylation. J Pediatr 1997: 130: 817-822.
19. BIOULAC SAGE P, PARROT ROULAUD F, MAZAT JP, et al. Fatal neonatal liver failure and mitochondrial cytopathy (oxidative phosphorylation deficiency): A light and electron microscopic study of the liver. Hepatology 1993: 18: 839-846.
20. BELL EA, SHAEFER MS, MARKIN RS, WOOD P, et al. Treatment of valproic acid associated hepatic failure with orthotopic liver transplantation. Ann Pharmacother 1992: 26: 18-21.
21. FENICHEL GM, GREENE HI. Valproate hepatotoxicity: Two new cases, a summary of others, and recommendations. Pediatr Neurol 1985: 1: 109-113.
22. THOMPSON MA, MCLAUGHIN D, EADIE M, et al. Orthotopic liver transplantation is unsuccessful for valproate associated liver failure in childhood: A need for critical risk benefit appraisal in the use of valproate. J Pediatr Gastroenterol Nutr 1995: 20: 451(Abstr.).
23. GONCALVES I, HERMANS D, CHRETIEN D, et al. Mitochondrial respiratory chain defect: a new etiology for neonatal cholestasis and early liver insufficiency. J Hepatol 1995: 23: 290-294.